BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11272137)

  • 1. Metabolic effects of restoring partial beta-cell function after islet allotransplantation in type 1 diabetic patients.
    Luzi L; Perseghin G; Brendel MD; Terruzzi I; Battezzati A; Eckhard M; Brandhorst D; Brandhorst H; Friemann S; Socci C; Di Carlo V; Piceni Sereni L; Benedini S; Secchi A; Pozza G; Bretzel RG
    Diabetes; 2001 Feb; 50(2):277-82. PubMed ID: 11272137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic effects of successful intraportal islet transplantation in insulin-dependent diabetes mellitus.
    Luzi L; Hering BJ; Socci C; Raptis G; Battezzati A; Terruzzi I; Falqui L; Brandhorst H; Brandhorst D; Regalia E; Brambilla E; Secchi A; Perseghin G; Maffi P; Bianchi E; Mazzaferro V; Gennari L; Di Carlo V; Federlin K; Pozza G; Bretzel RG
    J Clin Invest; 1996 Jun; 97(11):2611-8. PubMed ID: 8647955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol.
    Ryan EA; Lakey JR; Rajotte RV; Korbutt GS; Kin T; Imes S; Rabinovitch A; Elliott JF; Bigam D; Kneteman NM; Warnock GL; Larsen I; Shapiro AM
    Diabetes; 2001 Apr; 50(4):710-9. PubMed ID: 11289033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of current product release criteria for identification of human islet preparations suitable for clinical transplantation.
    Eckhard M; Brandhorst D; Winter D; Jaeger C; Jahr H; Bretzel RG; Brendel MD
    Transplant Proc; 2004 Jun; 36(5):1528-31. PubMed ID: 15251377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term function (6 years) of islet allografts in type 1 diabetes.
    Alejandro R; Lehmann R; Ricordi C; Kenyon NS; Angelico MC; Burke G; Esquenazi V; Nery J; Betancourt AE; Kong SS; Miller J; Mintz DH
    Diabetes; 1997 Dec; 46(12):1983-9. PubMed ID: 9392484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pancreas transplantation on free fatty acid metabolism in uremic IDDM patients.
    Luzi L; Groop LC; Perseghin G; Taskinen MR; Hilden H; Bianchi E; Terruzzi I; Dodesini AR; Di Carlo V; Pozza G
    Diabetes; 1996 Mar; 45(3):354-60. PubMed ID: 8593942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of blood glucose variability in type 1 diabetic patients treated by pancreatic islet transplantation: interest of continuous glucose monitoring.
    Kessler L; Passemard R; Oberholzer J; Benhamou PY; Bucher P; Toso C; Meyer P; Penfornis A; Badet L; Wolf P; Colin C; Morel P; Pinget M;
    Diabetes Care; 2002 Dec; 25(12):2256-62. PubMed ID: 12453970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-mimetic effects of short-term rapamycin in type 1 diabetic patients prior to islet transplantation.
    Benedini S; Ermetici F; Briganti S; Codella R; Terruzzi I; Maffi P; Caldara R; Secchi A; Nano R; Piemonti L; Alejandro R; Ricordi C; Luzi L
    Acta Diabetol; 2018 Jul; 55(7):715-722. PubMed ID: 29654388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired insulin-stimulated nonoxidative glucose metabolism in pancreas-kidney transplant recipients. Dose-response effects of insulin on glucose turnover.
    Christiansen E; Vestergaard H; Tibell A; Hother-Nielsen O; Holst JJ; Pedersen O; Madsbad S
    Diabetes; 1996 Sep; 45(9):1267-75. PubMed ID: 8772733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined pancreas and kidney transplantation normalizes protein metabolism in insulin-dependent diabetic-uremic patients.
    Luzi L; Battezzati A; Perseghin G; Bianchi E; Terruzzi I; Spotti D; Vergani S; Secchi A; La Rocca E; Ferrari G
    J Clin Invest; 1994 May; 93(5):1948-58. PubMed ID: 8182126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus.
    Warnock GL; Meloche RM; Thompson D; Shapiro RJ; Fung M; Ao Z; Ho S; He Z; Dai LJ; Young L; Blackburn L; Kozak S; Kim PT; Al-Adra D; Johnson JD; Liao YH; Elliott T; Verchere CB
    Arch Surg; 2005 Aug; 140(8):735-44. PubMed ID: 16103282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal focal steatosis of liver after islet transplantation in humans: a long-term study.
    Maffi P; Angeli E; Bertuzzi F; Paties C; Socci C; Fedeli C; De Taddeo F; Nano R; Di Carlo V; Del Maschio A; Secchi A
    Cell Transplant; 2005; 14(10):727-33. PubMed ID: 16454347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normalization of insulin sensitivity and glucose homeostasis in type I diabetic pancreas transplant recipients: a 48-month cross-sectional study--a clinical research center study.
    Cottrell DA
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3513-9. PubMed ID: 8855794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postabsorptive and insulin-stimulated energy homeostasis and leucine turnover in offspring of type 2 diabetic patients.
    Lattuada G; Sereni LP; Ruggieri D; Scollo A; Benedini S; Ragogna F; Costantino F; Battezzati A; Luzi L; Perseghin G
    Diabetes Care; 2004 Nov; 27(11):2716-22. PubMed ID: 15505010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of pancreas transplantation on postprandial glucose metabolism.
    Katz H; Homan M; Velosa J; Robertson P; Rizza R
    N Engl J Med; 1991 Oct; 325(18):1278-83. PubMed ID: 1922222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic effects of liver transplantation in cirrhotic patients.
    Luzi L; Perseghin G; Regalia E; Sereni LP; Battezzati A; Baratti D; Bianchi E; Terruzzi I; Hilden H; Groop LC; Pulvirenti A; Taskinen MR; Gennari L; Mazzaferro V
    J Clin Invest; 1997 Feb; 99(4):692-700. PubMed ID: 9045872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of glucagon-like peptide-1 on beta- and alpha-cell function in isolated islet and whole pancreas transplant recipients.
    Rickels MR; Mueller R; Markmann JF; Naji A
    J Clin Endocrinol Metab; 2009 Jan; 94(1):181-9. PubMed ID: 18957498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
    Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
    Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of glucose homeostasis in humans with denervated livers.
    Perseghin G; Regalia E; Battezzati A; Vergani S; Pulvirenti A; Terruzzi I; Baratti D; Bozzetti F; Mazzaferro V; Luzi L
    J Clin Invest; 1997 Aug; 100(4):931-41. PubMed ID: 9259593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful [correction of Succesful] transplantation of human islets in recipients bearing a kidney graft.
    Bertuzzi F; Grohovaz F; Maffi P; Caumo A; Aldrighetti L; Nano R; Hengster P; Calori G; Di Carlo V; Bonifacio E; Secchi A
    Diabetologia; 2002 Jan; 45(1):77-84. PubMed ID: 11845226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.